Peer Review History
| Original SubmissionNovember 13, 2024 |
|---|
|
Dear Dr. Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Mar 09 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Zinia Thajudeen Nujum Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following financial disclosure: “This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.” Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. Additional Editor Comments: ACADEMIC EDITOR Comments : Approaches and results of intersectoral actions for tuberculosis control in the world: A scoping review General The area of work is relevant and good attempt Specific comments The definition of intersectorality has not been provided , the PCC is not framed in a way to capture the question/objective and it appears that therefore the relevant studies have not been picked up Is population – Tuberculosis ? I think the concept needed to be broken down to name the sectors that we are specifically looking for and defined more accurately with search terms to represent all these. Why did the authors choose to register in Open Science Framework which is a broader platform and not PROSPERO meant specifically for reviews Line 128 – typo – intersectorality Context (C): National Tuberculosis Control Programs, National Tuberculosis Control Policy 130 and Tuberculosis Control Actions, Public Health - the national control program /policy , actions , public health – none of these figure in the search - Did the study really look at studies with intersectoral collaboration within the framework of national programs ? Methods – Was there a limit year ? Were studies in all languages included ? Include the search strategy and results from at least three databases in the supplementary material Table 3 – Yuen et al study the percentage of children under 5 years of age evaluated……(?increased ) from 70% to 90% was found. Was found may not be needed – check the sentence Table 3 – the approaches and results may be split into separate columns Conclusion – What is concluded from the paper are things that are already known. Can you include some new information from the article – since the objective is approaches and results of intersectoral actions can you bring in some best practice/approach in intersectoral action with remarkable results in TB control. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: No ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1. The review addresses a relevant topic, and the scoping review follows a strong methodology. However, the result section may be modified for better readability of the article. 2. What made the decision to include reviews, manuals, technical and governmental publications to be included in the review and editorials, experience reports, annals and books were excluded. The distinction is very narrow between many of the included and excluded categories, which can bring selection bias. Moreover, as reviews can use editorials and books along with original article, what is the point for exclusion criteria? 3. For the last column of table 2, the term ‘sample’ may be more appropriate than the term ‘population’. 4. Pushing data to the Table 3 is making both the table and the article in comprehensible. Better give the approaches and major intersectoral actions as short phrases or bullet points in the tables and give the details as running text. 5. The authors give two figures figure 2 and 3 illustrating approaches and results of intersectoral actions. However, the data is highly fragmented and listed under the candidate studies. It would be great if the authors can give a conceptual framework or a diagram illustrating the intersectoral actions in global TB control based on the collective wisdom they obtained from the review. The figure 2 and 3 could be shifted to the appendix if such a framework/diagram is made available. 6. The discussion and conclusion part of the manuscript should be significantly trimmed to get a focused view. Reviewer #2: The paper addresses an important topic on intersectoral actions on TB. The aim was to map various approaches and results of intersectoral actions for TB and the authors tried to do that through a scoping review. However, the reviewer could feel many significant issues 1. The search strategy and approach did not seem to have got all good documents and also did not have a good inclusion and exclusion criteria. Word intersectoral is too broad and it is difficult to get the correct studies/documents. It would have been good to relook, if possible and include the relevant studies. There is numerous adaptation of Multi sectoral accountability framework of WHO in various countries/regions with documented case studies, all those seems to have missed. 2. The included studies also seem to be very narrow and not adequately reflecting the theme. Some of them are just commentaries, many were reviews, some are very focused on outbreaks context, some on private sector engagement, some on community led monitoring. If such studies are included, there are a lot of similar studies (private sector engagement and community engagement itself have many good studies across the globe). Request to revisit and look for important studies. 3. Results of intersectoral actions are not very clear from the review, may need to synthesize better 4. Conclusion is not at all backed up with the results. Conclusion should be based on the results. Minor issues Word eradication, elimination, control is being used interchangeably without understanding the terminologies. Please relook and try to use appropriate terminologies. End TB and TB Elimination are used interchangeably- please relook (eg: Line 87-89- the statement seems wrong; it should be the other way. Also SDG is never intending to eliminate TB) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Gayathri AV Reviewer #2: Yes: RAKESH PS ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Silva, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 13 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Zinia Thajudeen Nujum, M.D Academic Editor PLOS ONE Additional Editor Comments: The comments on the revised manuscript from reviewer is given below. Please work on them for reconsidering publishing your article. Thanks for the reply and addressing the comments. The reviewer still feel that conclusion is not in alignment with the objectives and results. There are many generic statements which are not based on the results of this study. Based on the objective, a reader would like to hear as conclusion: What were the approaches used, what were the results, which ones were better and what are the learnings. Inclusion and exclusion of the studies are not clear yet to the reviewer. There are many good studies/reports excluded for the review. Local Government stewardship/ Private sector engagements/Community engagements etc. are some examples where lots of studies are available from high burden countries. There are not much studies from the high burden countries included in the scoping review. Request to highlight those as limitations. Word elimination, control is being used interchangeably. Request to relook again. Authors generally used TB control, still Elimination appears at 9 places. Kindly relook and choose appropriately. Also SDG never intends to 'eliminate' TB. Request to relook again (line 61-63) Also there is scope for making the writing crisp and comprehensive. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: (No Response) Reviewer #2: Thanks for the reply and addressing the comments. The reviewer still feel that conclusion is not in alignment with the objectives and results. There are many generic statements which are not based on the results of this study. Based on the objective, a reader would like to hear as conclusion: What were the approaches used, what were the results, which ones were better and what are the learnings. Inclusion and exclusion of the studies are not clear yet to the reviewer. There are many good studies/reports excluded for the review. Local Government stewardship/ Private sector engagements/Community engagements etc. are some examples where lots of studies are available from high burden countries. There are not much studies from the high burden countries included in the scoping review. Request to highlight those as limitations. Word elimination, control is being used interchangeably. Request to relook again. Authors generally used TB control, still Elimination appears at 9 places. Kindly relook and choose appropriately. Also SDG never intends to 'eliminate' TB. Request to relook again (line 61-63) Also there is scope for making the writing crisp and comprehensive. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: Gayathri A V Reviewer #2: Yes: RAKESH PS ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Approaches and results of intersectoral actions for tuberculosis control in the world: A scoping review PONE-D-24-48617R2 Dear Dr. Rosiane Davina da Silva, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Zinia Thajudeen Nujum, M.D Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes ********** Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: Yes: RAKESH PS ********** |
| Formally Accepted |
|
PONE-D-24-48617R2 PLOS ONE Dear Dr. Silva, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Zinia Thajudeen Nujum Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .